(Q37278407)

19 August 2017

Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice (English)

1 reference

19 August 2017

0 references

6

0 references

Lorenz C Hofbauer

9

0 references

Claudia Goettsch

2

object named as

Claudia Goettsch

1 reference

19 August 2017

8

Reinhold G Erben

1 reference

19 August 2017

Susann Helas

1

1 reference

19 August 2017

Michael Schoppet

3

1 reference

19 August 2017

Ute Zeitz

4

1 reference

19 August 2017

Ute Hempel

5

1 reference

19 August 2017

Henning Morawietz

6

1 reference

19 August 2017

Paul J Kostenuik

7

1 reference

19 August 2017

Lorenz C Hofbauer

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

9 July 2009

1 reference

The American Journal of Pathology

19 August 2017

1 reference

19 August 2017

175

1 reference

19 August 2017

473-478

1 reference

19 August 2017

2

1 reference

describes a project that uses

19 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2716948/fullTextXML

inferred from PubMed Central ID database lookup

cites work

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Vascular calcification and osteoporosis--from clinical observation towards molecular understanding

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Denosumab in postmenopausal women with low bone mineral density

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Molecular, endocrine, and genetic mechanisms of arterial calcification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716948

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification

3 September 2018

1 reference

12 December 2020

Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells

1 reference

12 December 2020

Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice

1 reference

12 December 2020

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

1 reference

12 December 2020

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

1 reference

12 December 2020

10.2353/AJPATH.2009.080957

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference